Senior Vice President of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX), Walkey Carl, sells 1,800 shares worth $21,360
According to Neoleukin Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Mar 04 06:52 PM, company Senior Vice President, Walkey Carl disclosed selling 1,800 shares at a cost of $11.87. At the time of this transaction (Mar 03), this trade was worth $21,360 in total. As of Mar 03, Walkey Carl now owns 1,373,362 shares in total worth about $15,697,527.66.
For the last few recent trades made by Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Senior Vice President, Walkey Carl, we have the following information:
- SEC Form 4 filing: Feb 25: Sold 600 shares at the rate of $13.00 per share. Total worth of this trade was $7,800. Total number of shares owned as of Feb 25 were 1,375,162
- SEC Form 4 filing: Feb 17: Sold 2,400 shares at the rate of $12.70 per share. Total worth of this trade was $30,480. Total number of shares owned as of Feb 17 were 1,377,562
- SEC Form 4 filing: Feb 10: Sold 3,000 shares at the rate of $14.20 per share. Total worth of this trade was $42,600. Total number of shares owned as of Feb 10 were 1,379,962
Posted by
George Daniels
on Thursday March 04 2021, 7:48 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
